AMERIPRISE FINANCIAL INC
Position in COLL — Collegium Pharmaceutical, Inc
CIK 820027
MINNEAPOLIS, MN
Position in COLL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,393,398
+$86,336 QoQ
Shares Held
66,116
-5.2% QoQ
Ownership
0.203%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#72
of 280 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 95%
None 5%
Common Shares in COLL Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $802,494,373 across 36 Drug Manufacturers - Specialty & Generic names. COLL ranks #19 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
18,815,747 | $298,794,060 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
502,267 | $84,652,078 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
619,298 | $68,704,917 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
123,215 | $66,761,581 | |
| 5 | ZTS |
Zoetis Inc.
|
812,181 | $58,363,324 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
1,396,427 | $34,366,066 | |
| 7 | ALKS |
Alkermes plc.
|
630,325 | $33,029,029 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
1,581,869 | $27,382,151 |
All Filings in COLL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,393,398 | 66,116 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,307,062 | 69,763 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,378,927 | 72,979 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,573,583 | 73,552 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,265,801 | 76,625 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,739,483 | 91,775 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $2,596,462 | 90,627 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $6,414,896 | 166,017 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,412,909 | 105,991 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,792,170 | 97,686 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,119,275 | 101,341 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,596,510 | 116,175 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,722,373 | 126,681 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,145,376 | 131,112 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $3,131,372 | 134,973 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,610,939 | 162,980 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,684,723 | 264,375 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $5,919,954 | 290,764 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,022,790 | 268,886 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,956,143 | 149,754 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,813,817 | 161,329 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $4,404,667 | 185,851 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,358,173 | 67,807 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,884,876 | 90,532 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,533,892 | 87,651 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,408,756 | 86,268 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||